Abstract
AbstractSilybum marianum, a remarkable medicinal plant displays multifarious medicinal properties including anticancer, hepatoprotective, antioxidant, immunomodulatory, anti‐inflammatory, neuroprotective, antibacterial and cosmeceutical properties. The promising antiproliferative potential of S. marianum demands further exploitation of bioactive compounds responsible for its medicinal properties. In the current study, Silybin B and (±)‐trans‐dehydrodiferulate dimethyl ester were isolated from S. marianum and characterized by NMR and FTIR spectroscopy. The antiproliferative activity of isolated compounds was investigated by sulforhodamine B assay against HeLa, HepG2 and BHK21 cell lines. Flow cytometery, DAPI, reactive oxygen species accumulation and comet assays were performed to validate the cytotoxic effect of potent compounds. Silybin B was more potent anticancer agent with an IC50 value of 23.85±5.98 μg/mL and 21.07±4.16 μg/mL against HeLa and HepG2 cell lines, respectively. The findings of all assays confirmed its apoptotic, cytotoxic and genotoxic effects on HeLa cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
